Investigation of loss of heterozygosity and SNP frequencies in the RET gene in papillary thyroid carcinoma.
In both medullary carcinoma and papillary carcinoma of the thyroid, altered expression of the RET gene is implicated in tumorigenesis. Recent studies suggest that loss of heterozygosity (LOH) at the G691S SNP may be associated with tumors from patients with a history of radiation exposure. We investigated LOH for three RET SNPs (G691S, S904S, and L769L) in tumor and normal tissue from 46 patients from Ukraine and Belarus who were exposed to radioactive fallout following the Chernobyl nuclear accident and were operated for papillary thyroid carcinoma between 1995 and 2000. Normal tissue from 28 patients was heterozygous for at least one SNP; DNA from the corresponding tumor samples was also heterozygous, indicating that no LOH had taken place. To assess SNP frequencies in a radiation-associated thyroid cancer cohort, we investigated a further 68 unpaired post-Chernobyl samples. For G691S, there was considerable deviation from Hardy-Weinberg equilibrium; more detailed analysis showed that this was linked to age at onset of disease. Among younger patients, the distribution of genotypes conformed to Hardy-Weinberg equilibrium; among older patients, we observed marked deviation (p = 0.0072), with significant over-representation of the rare S allele relative to the younger groups (Fisher's exact, p = 0.0233). This suggests that SNPs in the RET oncogene may play a role in sporadic papillary thyroid carcinoma.
Stephens
L A
LA
Human Cancer Studies Group, Swansea Clinical School, University of Wales, Swansea SA2 8PP, UK.
Powell
N G
NG
Grubb
J
J
Jeremiah
S J
SJ
Bethel
J A
JA
Demidchik
E P
EP
Bogdanova
T I
TI
Tronko
M D
MD
Thomas
G A
GA
D000293:Adolescent; D000328:Adult; D000368:Aged; D002291:Carcinoma, Papillary / Q000235:genetics*; D047852:Chernobyl Nuclear Accident; D002648:Child; D015331:Cohort Studies; D005787:Gene Frequency; D008040:Genetic Linkage; D006801:Humans; D019656:Loss of Heterozygosity; D008875:Middle Aged; D009381:Neoplasms, Radiation-Induced / Q000235:genetics*; D015513:Oncogene Proteins / Q000235:genetics*; D020641:Polymorphism, Single Nucleotide; D051096:Proto-Oncogene Proteins c-ret; D011847:Radioactive Fallout / Q000009:adverse effects; D020794:Receptor Protein-Tyrosine Kinases / Q000235:genetics*; D002094:Republic of Belarus; D013964:Thyroid Neoplasms / Q000235:genetics*; D014455:Ukraine
D015513:Oncogene Proteins; D011847:Radioactive Fallout; D051096:Proto-Oncogene Proteins c-ret; C099282:RET protein, human; D020794:Receptor Protein-Tyrosine Kinases